Clinical Trials Logo

Clinical Trial Summary

This study will test the effectiveness of using enhanced facilitation strategies on implementation of an automated Interactive Voice Response (IVR) system as a means to remotely deliver in-home self-management support to Veterans with chronic pain. The implementation intervention uses an enhanced facilitation approach paired with automated case finding and direct patient outreach to encourage uptake of Cooperative Pain Education and Self-management (COPES). A nested effectiveness study will measure pre-post differences in pain-relevant outcomes (pain intensity, physical functioning and physical activity). The investigators will use a stepped wedge cluster design in which clusters will be randomized to the timing of the introduction of enhanced COPES implementation. Investigators will assess the efficacy of the facilitation based implementation strategy by evaluating COPES uptake in the implementation settings.


Clinical Trial Description

Cognitive behavioral therapy (CBT) for chronic pain is a commonly used evidence-based self-management intervention. Though effective, CBT requires that patients attend multiple in-person visits and that highly trained staff be available to provide care. For these reasons CBT is resource intensive, often inaccessible to Veterans, and delivered unevenly across patients and facilities. In a Veterans Health Administration Office of Health Services Research and Development (HSR&D) IIR-funded trial, investigators found that CBT delivered primarily via an automated Interactive Voice Response (IVR) system (Cooperative Pain Education and Self-management or COPES) leads to patient-centered outcomes that are comparable to standard United States Department of Veterans Affairs (VA) approaches in which CBT is delivered in-person by a therapist over ten weekly sessions. In this study, implementation facilitation will be guided by the Consolidated Framework for Implementation Research (CFIR) which provides a set of constructs to identify potential barriers and facilitators to implementation. The primary objective of this project is to evaluate the effectiveness of the facilitation approach paired with automated case finding and direct patient outreach on uptake of COPES in the clinical care setting. Study investigators will specifically target Veterans who receive care at community-based outpatient clinics (CBOCs) because these sites typically have few or no therapists trained in CBT for chronic pain. Description of COPES: COPES is a 10-week, IVR-facilitated program of CBT for chronic pain. The primary components of COPES include: 1) a self-help handbook to teach Veterans pain self-management skills and describe the weekly skill practice goals, 2) a pedometer-facilitated progressive walking program (all COPES patients will be given an Omron Go Smart, Model HJ-112 pocket pedometer at the time of enrollment), and 3) daily, automated IVR calls to collect patient-reported pain intensity and pain-related interference, sleep quality, pedometer-measured step count, and adherence to the pain coping skill practice ratings. Participants will also receive a weekly, two to four minute pre-recorded, personalized therapist message via the IVR system based on the participant's IVR-recorded data. Therapists provide feedback on the participant's weekly average pain intensity, sleep, steps, and pain coping skill practice, note any changes from the prior week, and comment on symptom or activity patterns. Therapists also provide reinforcement for goal accomplishment, help patients make connections among pain, pain coping skill practice, and goal accomplishment, and assign a steps and skill practice goal for the upcoming week. Research Design: Study investigators will test the effectiveness of the facilitation approach to implement COPES as a means to remotely deliver in-home self-management support to Veterans with chronic pain. To evaluate the implementation's success, study investigators will conduct a multi-site, stepped wedge, Hybrid III trial in 17 CBOCs affiliated with three geographically dispersed sites (VA Boston, VA Palo Alto, and Roudebush VA in Indianapolis). Clusters (k=17 CBOCs) will be randomized to 6 different time periods proportional to approximate eligible patient population size. Each CBOC will serve as its own control for a period of time before "transitioning" into enhanced facilitation; the time of this transition is randomized in a stepped fashion. The primary outcome for evaluating implementation success will be patient enrollment in COPES. The secondary outcome will be provider referral. Other outcomes that will be investigated as part of the nested COPES effectiveness study will be Veterans' physical functioning, pain intensity, and physical activity. Methodology: Study investigators will evaluate the success of the implementation strategy by evaluating the proportion of patients who are offered enrollment in COPES who actually enroll. Additionally, study investigators will conduct a formative evaluation to inform, refine and evaluate implementation of COPES. The evaluation will include interviews with VA staff and patients with chronic back pain at the proposed implementation sites. Interview guides will be based on CFIR model constructs using questions adapted from the CFIR interview guide. Investigators will also measure pre-post differences in pain-relevant outcomes (pain intensity, physical functioning and physical activity). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02724930
Study type Interventional
Source VA Connecticut Healthcare System
Contact
Status Completed
Phase N/A
Start date June 25, 2018
Completion date August 27, 2020

See also
  Status Clinical Trial Phase
Completed NCT03243084 - Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy N/A
Suspended NCT04735185 - Stem Cells vs. Steroids for Discogenic Back Pain N/A
Completed NCT03162952 - RAND Center of Excellence for the Study of Appropriateness of Care in CAM
Completed NCT03240146 - Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain N/A
Completed NCT05282589 - Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients N/A
Completed NCT03637998 - Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain N/A
Recruiting NCT02289170 - Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100) N/A
Active, not recruiting NCT01944163 - The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain N/A
Completed NCT02231554 - Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial N/A
Recruiting NCT02063503 - Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients N/A
Terminated NCT01620775 - MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain N/A
Completed NCT01704677 - Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up N/A
Completed NCT01177280 - Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes N/A
Completed NCT01490905 - A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain Phase 4
Completed NCT01177254 - Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions N/A
Completed NCT01177241 - Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids N/A
Completed NCT00984815 - Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment Phase 3
Completed NCT00763321 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3
Completed NCT00767806 - A Study for Patient With Chronic Low Back Pain Phase 3
Completed NCT00761150 - Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP) Phase 3